Cadre Holdings, Inc.·4

Jun 18, 4:21 PM ET

Kissel Mary E. 4

4 · Cadre Holdings, Inc. · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Cadre Holdings (CDRE) Director Mary E. Kissel Receives Option Award

What Happened

  • Mary E. Kissel, a director of Cadre Holdings, Inc. (CDRE), was granted a derivative award of 17,393 options (reported as an acquisition) on 2026-06-16. The Form 4 reports a $0.00 per-share acquisition value (common for option grants); the filing does not state an exercise price or immediate cash value. This was a grant of options (an award), not a sale or immediate purchase of common stock.

Key Details

  • Transaction date: 2026-06-16; Form 4 filed: 2026-06-18.
  • Reported transaction: Grant/award of 17,393 derivative securities (options) at $0.00.
  • Vesting schedule (footnote): 4,349 options vest on June 30, 2026; 4,348 options vest on each of Sept 30, 2026; Dec 31, 2026; and Mar 31, 2027.
  • Shares owned after transaction: Not specified in the provided filing.
  • Filing timeliness: No late-filing indication in the information provided.
  • This is a grant of options (derivative securities), not an exercise or sale.

Context

  • Option grants are common compensation for directors; they give the right to buy company shares in the future if vested and exercised, so they do not represent immediate stock ownership or proceeds. Because the filing does not list an exercise price or any immediate sale, there is no immediate cash received or stock sold.

Insider Transaction Report

Form 4
Period: 2026-06-16
Transactions
  • Award

    Stock Option (right to purchase)

    [F1]
    2026-06-16+17,39317,393 total
    Exercise: $28.75Exp: 2036-06-16Common Stock (17,393 underlying)
Footnotes (1)
  • [F1]The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,349 shares of the Issuer's Common Stock will vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares of the Issuer's Common Stock will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027, respectively.
Signature
/s/ Mary E. Kissel|2026-06-18

Documents

1 file
  • 4
    tm2618182-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT